Non-Invasively Diagnosed NASH/MASH and NAFLD/MASLD

If you have  NASH/MASH or NAFLD/MASLD, you may qualify for one of our research studies.

Qualified volunteers may receive at no cost:

• investigational medication
• study-related care from a local doctor
• possible compensation

Health insurance isn’t required to participate.
Ask your doctor or contact our clinic for more information.

Or sign up below and we will contact you!

Study Information below is from Clinicaltrials.gov

Inclusion Criteria:

Main Study Only:

• Males and non-pregnant, non-lactating females between 18 – 80 (between 19-80 in the Republic of Korea) years of age inclusive, on the day of signing informed consent

• Previous history or presence of 2 out of 4 components of metabolic syndrome (obesity, dyslipidemia, elevated blood pressure, elevated fasting glucose) or type 2 diabetes

• Suspected or confirmed diagnosis of NASH/MASH or NAFLD/MASLD or non-invasively diagnosed NASH/MASH or NAFLD/MASLD

Open-Label Rollover

• Prior participation in the placebo arm of a previous Akero Phase 2 study

Exclusion Criteria:

• Other causes of liver disease based on medical history and/or liver histology and/or central laboratory results, including but not limited to: alcoholic liver disease, autoimmune disorders (e.g., primary biliary cholangitis [PBC], primary sclerosing cholangitis [PSC], autoimmune hepatitis), drug induced hepatotoxicity, Wilson disease, clinically significant iron overload, or alpha-1-antitrypsin deficiency

• Type 1 or unstable Type 2 diabetes

A reduced list of inclusion and exclusion criteria apply to participants in the open-label rollover extension.

Other inclusion and exclusion criteria may apply.